tradingkey.logo
tradingkey.logo
검색

Takeda Pharmaceutical Co Ltd

TAK
관심 목록에 추가
15.720USD
-0.120-0.76%
종가 06/24, 16:00ET시세는 15분 지연됩니다
50.21B시가총액
40.98P/E TTM

Takeda Pharmaceutical Co Ltd

15.720
-0.120-0.76%

자세한 내용은 Takeda Pharmaceutical Co Ltd 회사

Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.

Takeda Pharmaceutical Co Ltd 정보

종목 코드 TAK
회사 이름Takeda Pharmaceutical Co Ltd
상장일Jun 21, 2085
CEOWeber (Christophe)
직원 수47455
유형Depository Receipt
회계 연도 종료Jun 21
주소4F
도시CHUO-KU
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가Japan
우편 번호103-8668
전화81332782111
웹사이트https://www.takeda.com/
종목 코드 TAK
상장일Jun 21, 2085
CEOWeber (Christophe)

Takeda Pharmaceutical Co Ltd의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
7.60K
--
Mr. Christophe Weber
Mr. Christophe Weber
President, Chief Executive Officer, Representative Director
President, Chief Executive Officer, Representative Director
--
--
Dr. Andrew S. Plump, Ph.D.
Dr. Andrew S. Plump, Ph.D.
President of Research & Development, Director
President of Research & Development, Director
--
--
Mr. Tokumasa Takeda
Mr. Tokumasa Takeda
Global Finance Chief Accounting Officer & Corporate Controller
Global Finance Chief Accounting Officer & Corporate Controller
--
--
Mr. Michel Orsinger
Mr. Michel Orsinger
Independent Director
Independent Director
--
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
--
--
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
--
--
Mr. Koji Hatsukawa
Mr. Koji Hatsukawa
Independent Director
Independent Director
--
--
Mr. Jean-Luc Butel
Mr. Jean-Luc Butel
Independent Director
Independent Director
--
--
Mr. Ian T. Clark
Mr. Ian T. Clark
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
7.60K
--
Mr. Christophe Weber
Mr. Christophe Weber
President, Chief Executive Officer, Representative Director
President, Chief Executive Officer, Representative Director
--
--
Dr. Andrew S. Plump, Ph.D.
Dr. Andrew S. Plump, Ph.D.
President of Research & Development, Director
President of Research & Development, Director
--
--
Mr. Tokumasa Takeda
Mr. Tokumasa Takeda
Global Finance Chief Accounting Officer & Corporate Controller
Global Finance Chief Accounting Officer & Corporate Controller
--
--
Mr. Michel Orsinger
Mr. Michel Orsinger
Independent Director
Independent Director
--
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
--
--

자주 묻는 질문

Takeda Pharmaceutical Co Ltd의 상위 5대 주주는 누구인가요?

Takeda Pharmaceutical Co Ltd의 상위 5대 주주는 다음과 같습니다: Dr. John M. Maraganore, Ph.D.

Takeda Pharmaceutical Co Ltd(TAK)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Takeda Pharmaceutical Co Ltd의 주식을 보유한 기관은 총 637곳이며, 이들이 보유한 주식의 총 가치는 약 85.31M로 전체 발행 주식의 2.70%를 차지합니다. 이는 2025Q4 대비 -8142483.00 증가한 수치입니다.

Takeda Pharmaceutical Co Ltd의 최대 수익원은 무엇인가요?

2026Q1 기준, Takeda Pharmaceutical Co Ltd의 Gastrointestinal diseases 부문이 가장 높은 매출을 기록했으며, 금액은 385.81B로 전체 매출의 32.37%를 차지했습니다.
KeyAI